Brightpoint, IndyMac, Medivation, Janus: U.S. Equity Preview

By Lynn Thomasson

July 7 (Bloomberg) -- The following companies may have unusual price changes in U.S. markets tomorrow. Stock symbols are in parentheses after company names, and prices are as of 5:30 p.m. in New York, unless stated otherwise.

Brightpoint Inc. (CELL US): The provider of distribution services to communications industry said it may cut as many as 250 jobs from its European operations, in addition to the employee reductions reported June 30. The stock dropped 2.9 percent to $6.78 in regular trading.

Goodrich Petroleum Corp. (GDP US) dropped 3.3 percent to $68.38 in after-hours trading. The oil and natural gas explorer said it would sell 3 million shares and use a portion of the proceeds to repay debt. The sale of more stock may dilute earnings per share.

IndyMac Bancorp Inc. (IMB US) fell 30 percent to 50 cents. The mortgage company will cut more than half its workforce and said it's been unable to raise new capital as losses mount. Regulators have advised the company that it's no longer ``well capitalized,'' IndyMac said.

Medivation Inc. (MDVN US) gained 6.2 percent to $12.81 in extended trading. The drugmaker said a study showed its Dimebon medicine ``significantly'' improved cognitive function in people with mild-to-moderate Huntington's disease.

Janus Capital Group Inc. (JNS US): The money manager of more than $180 billion in assets agreed to purchase an additional 50 percent stake in Perkins, Wolf, McDonnell and Co. LLC, a Chicago- based money-management firm, for $90 million. Janus shares dropped 2.5 percent to $24.03 in regular trading.

To contact the reporter on this story: Lynn Thomasson in New York at lthomasson@bloomberg.net.